Bristol-Myers Squibb(CH:BMY)
CHF 49.37-1.45 (-2.84%)
CH:BMY
Bristol-Myers Squibb earnings date
CHF 49.37
At close:-1.45 (-2.84%)
Bristol-Myers Squibb (BMY) Q2 2026 Earnings Report
2 Followers
CH:BMY Q2 2026 EPS Results
- Actual EPS
- CHF 1.72
- Consensus EPS
- CHF 1.35
- Beat/Miss
- Beat by +CHF 0.37
- One Year Ago EPS
- CHF 1.23
CH:BMY Q2 2026 Revenue Results
- Actual Revenue
- CHF 10.95B
- Expected Revenue
- CHF 9.90B
- Beat/Miss
- Beat by +CHF 1.05B
- YoY Revenue Growth
- +5.81%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 07/30/2026
- Time
- Before Open
- Conference Call
- Thursday, July 30, 2026
CH:BMY Upcoming Earnings
Bristol-Myers Squibb's next earnings date is estimated for February 4, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
CH:BMY Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:BMY Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 04, 2027 | 2026 (Q4) | 1.27- | 1.06 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 0.931.14 | 1.38 | -17.18% (-0.24) | |
| Jul 30, 2026 | 2026 (Q2) | 1.351.72 | 1.23 | 39.73% (+0.49) | |
| Apr 30, 2026 | 2026 (Q1) | 1.201.33 | 1.52 | -12.22% (-0.19) | |
| Feb 05, 2026 | 2025 (Q4) | 1.031.06 | 1.41 | -24.55% (-0.35) | |
| Oct 30, 2025 | 2025 (Q3) | 1.281.38 | 1.52 | -9.44% (-0.14) | |
| Aug 01, 2025 | 2025 (Q2) | 0.921.23 | 1.75 | -29.47% (-0.51) | |
| Apr 24, 2025 | 2025 (Q1) | 1.261.52 | -3.71 | 140.91% (+5.23) | |
| Feb 06, 2025 | 2024 (Q4) | 1.231.41 | 1.43 | -1.76% (-0.03) | |
| Oct 31, 2024 | 2024 (Q3) | 1.261.52 | 1.69 | -10.00% (-0.17) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


